Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 3 of 3 results for emicizumab

  1. Emicizumab for preventing bleeding episodes in people with mild or moderate haemophilia A [ID5098]

    Suggested remit: To appraise the clinical and cost effectiveness of emicizumab within its marketing authorisation for preventing bleeding episodes in people wit...

    Technology appraisal guidance
    Topic selection

  2. Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over [ID6342]

    In development [GID-TA11397] Expected publication date: 26 February 2025

    Technology appraisal guidance
    In development

  3. Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A [ID6170]

    In development [GID-TA11106] Expected publication date: TBC

    Technology appraisal guidance
    In development